Sutimlimab May Be Discontinued in Some Patients With Cold Agglutinin Disease
Recommended
Sutimlimab May Be Discontinued in Some Patients With Cold Agglutinin Disease
In a post-trial observational study, several patients with cold agglutinin disease who had responded to sutimlimab demonstrated hematologic remission after discontinuation of treatment.
Access the full article to read more here.
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->